Rahn reinforces its anti-ageing portfolio
In vitro studies found Reforcyl to activate LXR in human primary keratinocytes and to activate key enzymes involved in epidermal lipid synthesis. Improvements in hydration, firmness, elasticity, smoothness and wrinkle depth around the eye area were confirmed in vivo.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
8 trends from in-cosmetics Global 2026: from ‘blue longevity’ to precision peptides
Read moreCosmetics Business walked the show floor to bring you our edit of the standout trends from this year’s beauty ingredient launches
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more. -
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.